Cytokines 2021 will combine the physical event at the Cardiff City Hall in the Centre of Cardiff, with the LabRoots Virtual Meeting platform for a unique experience bringing both the in-person and virtual community together. Online presentations will be intertwined with physical presentations and sessions including virtual interactions, live commentary, online chat & video chats, webcast video presentation and discussion. Tabletop Exhibits will be set up in the Marble Hall between all the meeting rooms. Virtual and Live exhibit booth engagement will be available through the LabRoots Virtual Meeting platform.
The 9th Annual Meeting of the International Cytokine starting on 17-10-2021 in Cardiff, United Kingdom has been evaluated as COMPLIANT with the MedTech Europe Code of Ethical Business Practice.
To confirm, please click here: and just fill in the Event ID: EMT23743
Cytokines 2021 Hybrid has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 18 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Full Sponsorship / Exhibitor Manual
View Sponsors from Cytokines 2020 Virtual Meeting:
Funding for this conference was made possible [in part] by a grant the National Institute of Health/National Institute of Allergy and Infectious Diseases (NIAID), 1R13AI154683-01, to the University of Washington. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Research reported in this publication was supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number R13AI140628. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.